Morgan Stanley
555 California Street, Suite 2100
San Francisco
California
94104
United States
Tel: 415-576-2326
452 articles with Morgan Stanley
-
BD Announces Cash Tender Offers by Morgan Stanley & Co. LLC
3/16/2022
BD, a leading global medical technology company announced that Morgan Stanley & Co. LLC has commenced cash tender offers for the notes set forth below, up to a maximum aggregate combined purchase price on such Notes payable in connection with such Offers) of $200,000,000.00.
-
Bristol Myers Squibb Enters Into $5 Billion Aggregate Accelerated Share Repurchase Agreements
2/9/2022
Bristol Myers Squibb (NYSE:BMY) today announced that it has entered into accelerated share repurchase (ASR) transactions under agreements with Morgan Stanley & Co. LLC, Barclays Bank PLC, Citibank, N.A. and JPMorgan Chase Bank, N.A., (collectively, the “ASR Agreements”) to repurchase, in aggregate, $5 billion of Bristol Myers Squibb common stock.
-
Morgan Stanley Announces $1.3 Million Grant to Columbia University Department of Psychiatry
11/16/2020
Funding will support research to better understand and address the impact of COVID-19 on children’s mental health
-
Morgan Stanley Announces Partnership with National Geographic Society, University of Georgia to Advance Citizen Science to Help Reduce Plastic Waste
11/13/2019
Partnership aims to engage citizen scientists and create a better understanding of debris and plastic pollution in coastlines and waterways through open data
-
3SBio's MSCI ESG Rating Upgraded to BBB, Ranking at the Forefront of the Global Biotechnology Industry
9/11/2019
According to Morgan Stanley Capital International's latest set of ESG ratings, 3SBio has been upgraded to BBB status, surpassing that of 61% of companies in the global biotechnology industry.
-
As the Morgan Stanley Global Healthcare Conference runs from September 12 through 14, numerous biopharma companies are making presentations, updating their operations and pipeline activities. Here’s a look at some of the highlights.
-
Belgium-based Galapagos NV snagged $300 million following its U.S. public offering of new ordinary shares in the form of American Depositary Shares.
-
WellCare Announces Appearance at Investor Conference on September 13, 2018
8/30/2018
WellCare Health Plans, Inc. today announced that members of its management team are scheduled to present at the Morgan Stanley 16th Annual Global Healthcare Conference on September 13, 2018, at approximately 8:35 a.m. EDT.
-
Top Wall Street biotech analysts are finding themselves in high demand, with staggering pay packages to go along with it, The Wall Street Journal reports.
-
Troubled Cempra Looks for a Lifeline, Hires Morgan Stanley to Review Options
3/13/2017
-
Teligent To Present At Morgan Stanley Global Healthcare Conference On September 13, 2016
9/13/2016
-
Quest Diagnostics To Speak At The Morgan Stanley Global Healthcare Conference
9/13/2016
-
Neurocrine Biosciences To Present At The Morgan Stanley Global Healthcare Conference
9/8/2016
-
Masimo To Present At Morgan Stanley Global Healthcare Conference
9/8/2016
-
IMPAX Labs To Present At The Morgan Stanley Global Healthcare Conference
9/7/2016
-
Halyard Health To Present At Morgan Stanley Global Healthcare Conference
9/7/2016
-
CryoLife To Present At Morgan Stanley Global Healthcare Conference
9/7/2016
-
Blueprint Medicines To Present At Morgan Stanley Global Healthcare Conference
9/7/2016
-
Axovant To Present At The Morgan Stanley Global Healthcare Conference
9/7/2016
-
Seattle Genetics To Present At Morgan Stanley Global Healthcare Conference
9/6/2016